Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States

Details

• Alternative Title:
  Genet Med
• Personal Author:
  Ream, Margie A. ; Lam, Wendy K.K. ; Grosse, Scott D. ; Ojodu, Jelili ; Jones, Elizabeth ; Prosser, Lisa A. ; Rosé, Angela M. ; Comeau, Anne Marie ; Tanksley, Susan ; Powell, Cynthia M. ; Kemper, Alex R.
• Description:
  Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is an X-linked condition caused by pathogenic variants in the iduronate-2-sulfatase gene. The resulting reduced activity of the enzyme iduronate-2-sulfatase leads to accumulation of glycosaminoglycans that can progressively affect multiple organ systems and impair neurologic development. In 2006, the US Food and Drug Administration approved idursulfase for intravenous enzyme replacement therapy for MPS II. After the data suggesting that early treatment is beneficial became available, 2 states, Illinois and Missouri, implemented MPS II newborn screening. Following a recommendation of the Advisory Committee on Heritable Disorders in Newborns and Children in February 2022, in August 2022, the US Secretary of Health and Human Services added MPS II to the Recommended Uniform Screening Panel, a list of conditions recommended for newborn screening. MPS II was added to the Recommended Uniform Screening Panel after a systematic evidence review reported the accuracy of screening, the benefit of presymptomatic treatment compared with usual case detection, and the feasibility of implementing MPS II newborn screening. This manuscript summarizes the findings of the evidence review that informed the Advisory Committee's decision.
• Subjects:
  Child Enzyme Replacement Therapy Glycosaminoglycans Humans Iduronate Sulfatase Iduronic Acid Infant, Newborn Mucopolysaccharidosis II Neonatal Screening
• Keywords:
  ACHDNC Evidence Review Hunter Syndrome Mucopolysaccharidosis Type II Newborn Screening
• Source:
  Genet Med. 25(2):100330
• Pubmed ID:
  36445366
• Pubmed Central ID:
  PMC9905270
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Place as Subject:
  United States
• Volume:
  25
• Issue:
  2
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:1004b51ea8dd7e0f9dec3e1b8d5804d6395ab95e29cbd6b4f3b6b490b3affb42
• Download URL:
  https://stacks.cdc.gov/view/cdc/124428/cdc_124428_DS1.pdf
• File Type:
  [PDF - 69.77 KB ]